Gender Concepts

Gender Concepts, Health Equity, and Sociocultural Influences

  • Sex vs. Gender:

    • Sex: Biological attributes including chromosomes, hormones, and reproductive anatomy in females, males, and intersex individuals.

    • Gender: Socially constructed roles, behaviors, expressions, and identities of women, men, girls, and boys that vary culturally and temporally.

  • Intersectionality & Hierarchy: Gender operates within social hierarchies; overlapping with ethnicity, socioeconomic status, disability, age, geography, and sexual orientation to compound disadvantage and discrimination.

  • Cross-Cultural Variations in Gender Roles:

    • Feudal Japan: Women managed household budgets and held property inheritance rights to free men for lordly service.

    • Tchambuli (Chambri): Women occupied dominant, managerial, hunting roles; men displayed traits traditionally viewed as feminine (adornment, jewelry) and mirrored labor pains as a cultural "social safety valve."

    • Arapesh: Mild-mannered society with complete equality in child-rearing and lack of distinct gender roles.

    • Mundugumor: Hostile, rivalrous dynamic between genders and generations; men exchanged female relatives for wives.

    • Matriarchal Lineages: Mosuo (matrilineal descent and naming), Minangkabau (women select and depose the male chief), Nagovisi, Garo, Bribri, and Umoja (all-female sanctuary in Kenya for survivors of gender-based violence).

  • Harmful Traditional Practices: Female genital mutilation (FGM), "breast ironing" (flattening developing breasts to avert sexual attention in parts of Cameroon), and ritual finger joint amputation during mourning among the Dani people of Papua, Indonesia.


Dani woman showing amputated finger joints as a traditional grief ritual
  • Global Gender Inequality Metrics:

    • Global gender gap is 68.8%68.8\% closed, requiring 123 years123\,\text{years} to achieve full parity; zero countries have reached total equality (Iceland ranked #1 for 16 consecutive years; Türkiye ranked 135th of 148; World Economic Forum 2025).

    • Northern Cyprus (TRNC, 2023): Labor force participation is 61.9%61.9\% for men vs. 38.3%38.3\% for women; political representation includes 11/5011/50 Members of Parliament, 1/181/18 mayors, and 0/100/10 cabinet ministers.

  • Violence Against Women & Conventions:

    • 1 in 31\,\text{in}\,3 women globally experience physical or sexual intimate partner violence or non-partner sexual violence.

    • CEDAW (1979): UN treaty on eliminating discrimination against women; adopted by the TRNC Assembly on March 8, 1996.

    • Istanbul Convention (2011): Council of Europe framework against gender-based violence; Türkiye withdrew in 2021.

  • Transgender and Intersex Clinical Care:

    • Clinicians must inventory and screen organs present (cervix, uterus, ovaries, breast tissue) regardless of listed gender marker.

    • Exogenous testosterone is not a contraceptive; pregnancy remains possible in trans men retaining ovaries/uterus, and testosterone is teratogenic.

    • Gender-affirming testosterone causes vaginal tissue atrophy, complicating speculum exams and cervical sampling.

Reproductive Anatomy and Embryological Development

  • Embryological Differentiation: Male and female external genitalia differentiate from common rudimentary structures (genital tubercle, urethral folds, and labioscrotal swellings).


Differentiation of male and female external genitalia from rudimentary components
  • External Female Genitalia (Vulva) & Perineum:

    • Mons Pubis: Subcutaneous fatty pad anterior to the symphysis pubis.

    • Labia Majora & Minora: Outer fat-filled hair-bearing folds protecting delicate inner vascular folds.

    • Clitoris: Erectile cylindrical organ at the superior junction of labia minora.

    • Vestibule: Region enclosed by labia minora containing the urethral meatus, vaginal orifice, hymen, and lubricating Bartholin glands.

    • Perineal Musculature: Supports pelvic viscera, regulates vaginal and anal sphincters, and assists fetal head rotation.


Female perineal anatomy including external genitalia landmarks and superficial muscles
  • Internal Female Genitalia:

    • Ovaries: Paired gonads tethered by ovarian ligaments; regulate gamete storage/maturation and secrete estrogen and progesterone.

    • Fallopian Tubes: Facilitate fertilization across 5 anatomic zones: fimbriae, infundibulum, ampulla (primary fertilization site), isthmus, and interstitium.

    • Uterus: Muscular organ comprising fundus, corpus, and cervix; structural layers include endometrium (functional mucosa), myometrium (smooth muscle), and perimetrium (serosa). Mass enlarges from 40−50 g40-50\,\text{g} (non-pregnant) to 1,100−1,200 g1,100-1,200\,\text{g} at term via myometrial cell hypertrophy.

    • Vagina: Fibromuscular canal (8−10 cm8-10\,\text{cm}) with transverse rugae; maintained at an acidic pH by Döderlein bacilli to prevent infection.

  • Male Reproductive Anatomy:

    • External Organs: Penis (shaft, glans, foreskin, corpus cavernosum, corpus spongiosum; flaccid length 5−9 cm5-9\,\text{cm}, diameter 3−5 cm3-5\,\text{cm}); scrotum (houses testes at 2∘C2^\circ\text{C} below core body temperature).

    • Internal Organs: Testes (seminiferous tubules produce sperm and testosterone via Leydig cells); epididymis (head, body, tail; stores and matures sperm); vas deferens (transports sperm to ejaculatory ducts).

    • Accessory Glands: Seminal vesicles, prostate gland, and bulbourethral (Cowper's) glands produce alkaline seminal fluid.


Internal structural anatomy of the testis, seminiferous tubules, and epididymis
  • Seminal Fluid Densities (per cc):

    • Normosperm: 60−120×106 sperm60-120\times 10^6\,\text{sperm}.

    • Oligosperm: 30−60×106 sperm30-60\times 10^6\,\text{sperm}.

    • Hyposperm: 1−30×106 sperm1-30\times 10^6\,\text{sperm}.

    • Azospermia: Total absence of sperm.

    • Necrospermia: Sperm present but immobile/non-viable.

  • Mammary Gland Architecture: Lobes containing milk-producing alveoli drain through lactiferous ducts toward the nipple; areola darkens and enlarges during pregnancy under hormonal regulation.

Gametogenesis and Ovarian-Endometrial Cycles

  • Comparative Gametogenesis:

    • Oogenesis: Mitotic replication of oogonia finishes by the 5th month of fetal gestation. Primary oocytes (2n=462n = 46) arrest in prophase of meiosis I until puberty. Approximately 500,000500,000 follicles exist at birth; roughly 400400 reach mature ovulation throughout life (the rest undergo atresia). Meiosis I produces a secondary oocyte (n=23n = 23) and the first polar body. Meiosis II completes only upon fertilization, generating a mature ovum and a second polar body.

    • Spermatogenesis: Begins at puberty and persists continuously in seminiferous tubules. Spermatogonia (2n=462n = 46) divide mitotically to produce primary spermatocytes (2n2n). Meiosis I produces secondary spermatocytes (n=23n = 23); Meiosis II yields four haploid spermatids (n=23n = 23) that differentiate into spermatozoa.


Comparative stages of spermatogenesis and oogenesis resulting in fertilization
  • Neuroendocrine Feedback Loops:

    • Hypothalamic-Pituitary-Gonadal Axis: Hypothalamic GnRH stimulates pituitary release of FSH and LH.

    • Male Regulation: FSH acts on Sertoli cells to initiate spermatogenesis and produce inhibin (which feeds back negatively on the anterior pituitary). LH stimulates interstitial Leydig cells to secrete testosterone.


Hormonal feedback loop between the hypothalamus, pituitary gland, and testicle
  • Ovarian Cycle Phases:

    • Follicular Phase (Days 1–14): FSH stimulates follicular maturation; dominant Graafian follicle produces increasing estrogen, which suppresses FSH (negative feedback) and triggers the mid-cycle LH surge (positive feedback).

    • Ovulation (Days 12–14): LH peak causes follicle rupture and expulsion of the secondary oocyte.

    • Luteal Phase (Days 14–28): Ruptured follicle transforms into the corpus luteum, secreting high levels of progesterone and modest estrogen. In the absence of fertilization, the corpus luteum degenerates into the fibrous corpus albicans.

  • Endometrial (Uterine) Cycle Phases:

    • Proliferative Phase (Days 5–14): Estrogen rebuilds the functional layer (stratum spongiosum and stratum compactum) from the baseline stratum basalis, causing glandular and arteriolar elongation.

    • Secretory Phase (Days 14–28): Progesterone induces glandular tortuosity, glycogen secretion, and vascular engorgement. If fertilization does not occur, vascular spasm of spiral arteries leads to tissue ischemia.

    • Menstrual Phase (Days 1–5): Sloughing of the functional layer; average blood loss is 30−100 cc30-100\,\text{cc}. Menstrual blood does not clot due to locally released proteolytic enzymes that destroy fibrinogen.

Fertilization, Embryonic Differentiation, and Fetal Physiology

  • Fertilization Kinetics: Secondary oocytes remain viable for 24 hours24\,\text{hours} post-ovulation; sperm retain viability for 48−72 hours48-72\,\text{hours}, establishing a 3-day3\text{-day} conception window (2 days2\,\text{days} pre-ovulation to 1 day1\,\text{day} post-ovulation). Penetration of the corona radiata and zona pellucida triggers the cortical reaction to prevent polyspermy.

  • Pre-Implantation Cleavage Stages: Zygote divides mitotically without cell enlargement to form a solid morula (16+ cells16+\text{ cells}), followed by a fluid-filled blastocyst (outer trophoblast and inner cell mass) at 4.5−5 days4.5-5\,\text{days}.

  • Implantation: Occurs at day 6 post-fertilization in the endometrium; the invading trophoblast secretes proteolytic enzymes and human chorionic gonadotropin (hCG\text{hCG}) to sustain the ovarian corpus luteum.


Blastocyst structure and trophoblastic invasion into the endometrial uterine wall
  • Embryonic Membranes and Germ Layers:

    • Germ Layers: Ectoderm (nervous system, epidermis), Mesoderm (skeletal, muscular, circulatory systems), and Endoderm (epithelial lining of respiratory and digestive tracts).

    • Membranes: Inner amnion and outer chorion enclose the amniotic cavity. The yolk sac generates early blood and germ cells.


Embryonic disc germ layers, extraembryonic cavities, and early chorionic villi
  • Placental Anatomy and Endocrinology:

    • Composed of maternal decidua basalis and fetal chorionic villi organized into 15−2015-20 cotyledons.

    • Transport: Simple diffusion (O2\text{O}_2, CO2\text{CO}_2, electrolytes), facilitated diffusion (glucose), active transport (amino acids, calcium, iron, vitamins), pinocytosis (antibodies, albumin).

    • Endocrine Secretions: hCG\text{hCG} (preserves corpus luteum), human placental lactogen (hPL\text{hPL}, induces maternal insulin resistance to spare glucose for the fetus), estrogen (uterine and mammary growth), progesterone (myometrial relaxation), relaxin (pelvic ligament laxity).

  • Amniotic Fluid Dynamics:

    • Normal term volume: 700−1,000 cc700-1,000\,\text{cc}.

    • Oligohydramnios: <500 mL<500\,\text{mL} (associated with renal agenesis, uteroplacental insufficiency, pulmonary hypoplasia).

    • Polyhydramnios: >2,000 mL>2,000\,\text{mL} (associated with gastrointestinal atresia, maternal diabetes, neural tube defects).

  • Fetal Developmental Milestones:

    • Day 35: Tubular heart begins regular contraction; limb buds and optic vesicles emerge.

    • Week 8: Transition from embryonic to fetal stage; all major organ systems rudimentary.

    • Weeks 16–20: Quickening (maternal perception of movement).

    • Week 30: Skin covered with lanugo (fine downy hair) and vernix caseosa; surfactant production remains immature prior to 34−36 weeks34-36\,\text{weeks}.


Fetus at 30 weeks gestation displaying facial features, vernix, and lanugo
  • Fetal Cardiovascular Shunts:

    • Ductus Venosus: Shunts oxygenated umbilical vein blood past the hepatic sinusoids directly into the inferior vena cava (IVC\text{IVC}; closes to form ligamentum venosum).

    • Foramen Ovale: Interatrial septum aperture directing oxygenated blood from the right atrium directly into the left atrium (closes to form fossa ovalis).

    • Ductus Arteriosus: Vascular conduit diverting deoxygenated blood from the pulmonary trunk into the descending aorta (closes to form ligamentum arteriosum).

    • Umbilical Cord: Comprises two umbilical arteries (carrying deoxygenated fetal blood to the placenta) and one umbilical vein (carrying oxygenated blood to the fetus), protected by Wharton's jelly.

Maternal Assessment and Diagnostic Testing

  • Gestational Timing Classifications:

    • Preterm: Birth before 3737 completed weeks of gestation.

    • Full-Term: Delivery between 3737 and 4040 weeks of gestation.

    • Post-Term: Pregnancy extending to 4242 weeks or beyond.

  • Obstetric Parity Documentation:

    • Gravida: Total number of pregnancies regardless of duration.

    • Para: Number of pregnancies reaching viability (≥20 weeks\ge 20\,\text{weeks}) delivered alive or stillborn.

    • GTPAL System: Gravida, Term (≥37 weeks\ge 37\,\text{weeks}), Preterm (20−366/7 weeks20-36^{6/7}\,\text{weeks}), Abortions (<20 weeks<20\,\text{weeks}, spontaneous or induced), Living children.

  • Probable and Presumptive Clinical Signs of Pregnancy:

    • Goodell Sign: Softening of the cervix.

    • Chadwick Sign: Bluish-purple discoloration of the cervix and vaginal mucosa secondary to pelvic hypervascularity.

    • Hegar Sign: Softening of the lower uterine segment (isthmus).

    • Braun-Fernwald Sign: Asymmetrical enlargement and localized softening at the uterine fundal implantation site.

  • Estimating Gestational Age and Due Dates:

    • Naegele's Rule:     Estimated Date of Delivery (EDD)=LMP+7 days−3 months+1 year\text{Estimated Date of Delivery (EDD)} = \text{LMP} + 7\,\text{days} - 3\,\text{months} + 1\,\text{year}

    • McDonald's Rule:     Gestational Age (weeks)=Fundal Height (cm)×87\text{Gestational Age (weeks)} = \text{Fundal Height (cm)} \times \frac{8}{7}     Gestational Age (lunar months)=Fundal Height (cm)×27\text{Gestational Age (lunar months)} = \text{Fundal Height (cm)} \times \frac{2}{7}

    • Fundal Height Milestones: Detectable above pubic symphysis at 12 weeks12\,\text{weeks}; reaches umbilicus at 20 weeks20\,\text{weeks}; measurement in centimeters correlates with gestational age (±2 cm\pm 2\,\text{cm}) between 2020 and 36 weeks36\,\text{weeks}.


Fundal height height landmarks on the maternal abdomen across gestational weeks
  • Pelvic Landmarks: True pelvis consists of the pelvic inlet (bounded by sacral promontory, arcuate lines, and pubic symphysis) and pelvic outlet (bounded by ischial tuberosities, sacrotuberous ligaments, and coccyx).


Anatomical boundaries of the maternal pelvic inlet and pelvic outlet

Fetal Health Surveillance and Screening Modalities

  • Maternal Kick Counting: Evaluated starting at 27−28 weeks27-28\,\text{weeks}. The mother lies in a lateral position post-prandially and tracks movements. A reassuring score is at least 10 movements10\,\text{movements} within 2 hours2\,\text{hours}. A sudden cessation or acute drop in activity represents a high risk for fetal compromise (associated with a 60-fold60\text{-fold} increase in stillbirth).

  • Biophysical Profile (BPP): Scored out of 1010 points (22 points for normal, 00 points for abnormal criteria across a 30-minute30\text{-minute} window):

    • Fetal Heart Rate: Reactive Nonstress Test (≥2\ge 2 accelerations of 15 bpm15\,\text{bpm} for 15 seconds15\,\text{seconds}).

    • Fetal Breathing Movements: ≥1\ge 1 episode lasting >30 seconds>30\,\text{seconds}.

    • Gross Body Movements: ≥3\ge 3 discrete trunk or limb movements.

    • Fetal Tone: ≥1\ge 1 episode of active extension and return to flexion of an extremity or hand.

    • Amniotic Fluid Volume: Single deepest vertical pocket ≥2 cm\ge 2\,\text{cm} or amniotic fluid index (AFI\text{AFI}) ≥5 cm\ge 5\,\text{cm}.

  • Electronic Fetal Monitoring:

    • Nonstress Test (NST): Assesses fetal heart rate acceleration in response to fetal movement. Reactive criteria: two 15 bpm15\,\text{bpm} accelerations lasting 15 seconds15\,\text{seconds} within 20 minutes20\,\text{minutes}.

    • Contraction Stress Test (CST): Evaluates uteroplacental respiratory reserve under induced contractions (nipple stimulation or IV oxytocin). Contraindicated in placenta previa, marginal abruption, previous classical cesarean incision, cervical insufficiency, and risk for preterm labor.

  • Invasive Diagnostic Modalities:

    • Amniocentesis: Transabdominal needle aspiration of amniotic fluid guided by ultrasound at 16−18 weeks16-18\,\text{weeks}; evaluates karyotype, fetal lung maturity, and infections. Complications: fetal loss (0.3−0.5%0.3-0.5\%), needle injury, fetomaternal hemorrhage, Rh isoimmunization (requires RhoGAM administration to Rh-negative mothers post-procedure).

    • Chorionic Villus Sampling (CVS): Biopsy of placental trophoblastic tissue transcervically or transabdominally at 10−13 weeks10-13\,\text{weeks} (earlier than amniocentesis). Analyzes chromosomal abnormalities; does not detect neural tube defects.

    • Percutaneous Umbilical Blood Sampling (PUBS / Cordocentesis): Direct ultrasound-guided blood aspiration from the umbilical vein for fetal karyotype, hemoglobinopathies, platelet disorders, and blood typing.

  • Serum Biochemical Screening:

    • First Trimester Double Marker: 11−14 weeks11-14\,\text{weeks} (PAPP-A\text{PAPP-A} and free β-hCG\beta\text{-hCG} combined with nuchal translucency ultrasound).

    • Second Trimester Triple Screen: 15−20 weeks15-20\,\text{weeks} (maternal serum alpha-fetoprotein [MSAFP], hCG\text{hCG}, and unconjugated estriol [uE3u\text{E}_3]).

    • Quad Marker Screen: 15−20 weeks15-20\,\text{weeks} (adds Inhibin A; predicts 75−80%75-80\% of open neural tube defects and screens for Trisomy 21 and 18).

  • Group B Streptococcus (GBS) Screening: Rectovaginal swab performed at 35−37 weeks35-37\,\text{weeks}; positive carriers require intrapartum IV antibiotic prophylaxis to prevent neonatal sepsis, pneumonia, and meningitis.

Antenatal Care Models and Maternal Health Conditions

  • WHO Antenatal Care (ANC) Guidelines:

    • Minimum of 8 contacts initiated in gestational weeks 8−128-12.

    • Routine Interventions: Daily oral elemental iron (30−60 mg30-60\,\text{mg}) and folic acid (400 μg400\,\mu\text{g} / 0.4 mg0.4\,\text{mg}) to prevent maternal anemia, puerperal sepsis, and low birth weight; routine early ultrasound before 24 weeks24\,\text{weeks} (ideally 17−19 weeks17-19\,\text{weeks}) for gestational dating and anatomical survey.

    • Screening & Prophylaxis: Asymptomatic bacteriuria (7-day antibiotic course to prevent pyelonephritis/preterm birth), tetanus toxoid immunization, HIV provider-initiated counseling/testing, intimate partner violence screening.

    • Symptom Management: Ginger, vitamin B6\text{B}_6, or chamomile for nausea; dietary adjustments/antacids for heartburn; support belts and exercise for lower back pain; wheat bran/fiber for constipation; compression stockings for peripheral edema.

  • Cardiac Disease in Pregnancy:

    • Maternal blood volume expands by 30−50%30-50\%, peaking at 32 weeks32\,\text{weeks}.

    • NYHA Functional Classes: Class I (asymptomatic during normal activity); Class II (symptomatic with moderate exertion); Class III (symptomatic with light daily activity); Class IV (symptomatic at rest; severe maternal risk).

    • Management: Limit sodium, optimize rest (side-lying to maximize venous return), avoid Valsalva during pushing (operative delivery via vacuum or forceps indicated), use subcutaneous low-molecular-weight heparin instead of warfarin (teratogenic).

  • Gestational Diabetes Mellitus (GDM):

    • Pathophysiology: Placental release of hPL\text{hPL}, estrogen, and progesterone promotes maternal peripheral insulin resistance during the second and third trimesters to divert glucose to the growing fetus.

    • Diagnostic Thresholds (100 g100\,\text{g} 3-hour OGTT): Fasting ≥105 mg/dL\ge 105\,\text{mg/dL}, 1-hour ≥190 mg/dL\ge 190\,\text{mg/dL}, 2-hour ≥165 mg/dL\ge 165\,\text{mg/dL}, 3-hour ≥145 mg/dL\ge 145\,\text{mg/dL}.

    • Risks: Fetal macrosomia (>4,000 g>4,000\,\text{g}), birth trauma, neonatal hypoglycemia, hyperbilirubinemia, polycythemia, respiratory distress syndrome (insulin inhibits surfactant production).

  • Anemias in Pregnancy: Defined as Hemoglobin <11 g/dL<11\,\text{g/dL} in the 1st/3rd trimesters and <10.5 g/dL<10.5\,\text{g/dL} in the 2nd trimester.

    • Iron Deficiency: Administer oral iron with Vitamin C on an empty stomach; causes dark stools and constipation.

    • Folic Acid Deficiency: Megaloblastic anemia; requires daily preconceptional and antenatal supplementation.

    • Sickle Cell Anemia: Autosomal recessive hemoglobin S (HbS\text{HbS}); painful vaso-occlusive crises triggered by dehydration, hypoxia, or cold; managed with IV hydration, oxygen, analgesia, and antiembolic measures.

    • Thalassemia: Quantitative defect in beta-globin synthesis; Thalassemia Major requires lifelong transfusions leading to iron overload.

  • Rh Isoimmunization (Erythroblastosis Fetalis): Rh-negative mothers carrying an Rh-positive fetus produce anti-D antibodies if fetal RBCs cross the placenta during delivery, miscarriage, or invasive procedures. Subsequent Rh-positive fetuses suffer hemolytic anemia and hydrops fetalis. Administer RhoGAM (anti-D immune globulin\text{anti-D immune globulin}) within 72 hours72\,\text{hours} of delivery or sensitizing events.

  • TORCH Infections:

    • Toxoplasmosis: Protozoan via undercooked meat/cat feces; treated with sulfadiazine and pyrimethamine.

    • Other (Syphilis): Screened via VDRL/RPR; treated with Penicillin G; untreated causes congenital syphilis and fetal death.

    • Rubella: Transplacental virus causing congenital rubella syndrome (cataracts, microcephaly, sensorineural deafness); live MMR vaccine is contraindicated during pregnancy.

    • Cytomegalovirus (CMV): Leading cause of congenital sensorineural hearing loss and microcephaly.

    • Herpes Simplex Virus 2 (HSV-2): Painful vesicular lesions; active lesions during labor mandate cesarean birth.

Obstetric Complications: Bleeding, Hypertensive, and Membrane Disorders

  • Spontaneous Abortion Classifications (<20 weeks<20\,\text{weeks}):

    • Threatened: Vaginal bleeding without cervical dilation or tissue passage.

    • Inevitable: Bleeding with progressive cervical dilation and membrane rupture.

    • Incomplete: Partial expulsion of fetal or placental tissues; residual products in utero require dilation and curettage (D&C).

    • Complete: Total spontaneous evacuation of all conceptus tissue; cervix closes.

    • Missed: Non-viable intrauterine fetus retained without bleeding or cervical changes.

  • Ectopic Pregnancy: Implantation outside the uterine cavity (98%98\% occur in fallopian tubes, primarily the ampulla). Symptoms: unilateral pelvic pain, delayed menses, irregular bleeding, and referred shoulder pain (diaphragmatic irritation from hemoperitoneum). Diagnosed by transvaginal ultrasound and serum β-hCG\beta\text{-hCG}; managed with intramuscular methotrexate or salpingostomy/salpingectomy.


Anatomical sites of ectopic implantation in the female reproductive tract
  • Third-Trimester Hemorrhagic Disorders:

    • Placental Abruption (Abruptio Placentae): Premature detachment of the placenta from the uterine wall. Characterized by painful, dark red vaginal bleeding (or occult concealed hemorrhage in 10−20%10-20\%), rigid "board-like" uterus, and fetal distress. Risk factors: hypertension, cocaine use, abdominal trauma.

    • Placenta Previa: Placental implantation over or encroaching upon the internal cervical os (complete, partial, marginal). Characterized by painless, bright red vaginal bleeding. Digital vaginal examinations are strictly contraindicated until ultrasound confirms location.


Degrees of placenta previa: low lying, marginal, partial, and complete
  • Placenta Accreta Spectrum: Deficient decidua basalis causes direct placental anchoring to the myometrium (accreta), invasion into the myometrium (increta), or full penetration through the uterine serosa (percreta); high risk for massive postpartum hemorrhage.

  • Vasa Previa: Fetal vessels traverse membranes across the internal cervical os unsupported by Wharton's jelly; membrane rupture causes rapid fetal exsanguination.

    • Hypertensive Disorders of Pregnancy:

  • Gestational Hypertension: Blood pressure >140/90 mm Hg>140/90\,\text{mm Hg} occurring after 20 weeks20\,\text{weeks} gestation without proteinuria on two readings 4 hours4\,\text{hours} apart; normalizes by 12 weeks12\,\text{weeks} postpartum.

  • Preeclampsia: New-onset hypertension (>140/90 mm Hg>140/90\,\text{mm Hg}) after 20 weeks20\,\text{weeks} with proteinuria (≥0.3 g\ge 0.3\,\text{g} in a 24-hour urine collection) or end-organ dysfunction (thrombocytopenia, renal insufficiency, impaired liver function, visual scotomata, epigastric pain).

  • Eclampsia: Occurrence of grand mal seizures in a patient with preeclampsia.

  • HELLP Syndrome: Severe variant marked by Hemolysis, Elevated Liver enzymes, and Low Platelets.

    • Magnesium Sulfate Nursing Protocol:

  • Primary agent for seizure prophylaxis and neuroprotection.

  • Toxicity Surveillance: Continuous monitoring of respiratory rate (must be ≥16/min\ge 16/\text{min} before every dose), deep tendon reflexes (patellar reflex must be present), and urinary output (must be ≥100 mL\ge 100\,\text{mL} every 4 hours4\,\text{hours} or ≥30 mL/hr\ge 30\,\text{mL/hr}).

  • Antidote: Calcium gluconate.

    • Premature Rupture of Membranes (PROM & PPROM):

  • PROM: Rupture of chorioamniotic membranes prior to labor onset.

  • Preterm PROM (PPROM): Membrane rupture occurring before 37 weeks37\,\text{weeks}; carries risks of chorioamnionitis, cord prolapse, and fetal lung hypoplasia. Managed with expectant monitoring, prophylactic antibiotics, and corticosteroids (betamethasone) between 2424 and 34 weeks34\,\text{weeks} to accelerate fetal lung surfactant synthesis.

Labor Physiology, the Three Ps, and Intrapartum Nursing Care

  • Theories of Labor Onset:

    • Maternal Mechanisms: Myometrial stretch stimulates prostaglandin release; presenting part pressure stimulates the neuroendocrine Ferguson reflex (pulsatile oxytocin secretion from the posterior pituitary). Estrogen levels rise while progesterone falls, lowering myometrial excitation thresholds.

    • Fetal Mechanisms: Maturing fetal hypothalamic-pituitary-adrenal axis elevates fetal cortisol, signaling the placenta to downregulate progesterone synthesis and synthesize prostaglandins from membrane arachidonic acid.

  • Premonitory Signs of Approaching Labor: Lightening (fetal descent into the pelvic inlet, occurring around 38 weeks38\,\text{weeks} in primigravidas), increased pelvic pressure, Braxton Hicks contractions, cervical effacement, and bloody show (mucus plug expulsion with capillary rupture).

  • The Three Ps of Labor:

    • Power:

    • Primary: Involuntary uterine contractions defined by frequency (time from the start of one contraction to the start of the next), duration (length of contraction from onset to relaxation), and intensity (palpated mild, moderate, or strong).

    • Secondary: Voluntary intra-abdominal bearing-down efforts by the mother.


Waveform graph of a uterine contraction showing increment, acme, decrement, and resting tone
  • Passenger: The fetus.

    • Fetal Lie: Longitudinal (parallel axes), transverse (perpendicular axes), or oblique.

    • Fetal Attitude: Degree of head flexion (complete flexion is ideal; military position; extension/brow/face).

    • Presentation: Cephalic (vertex), breech (frank, complete, footling), or shoulder.

    • Station: Fetal descent measured in centimeters relative to maternal ischial spines (−5 cm-5\,\text{cm} to +5 cm+5\,\text{cm}; 0 station0\,\text{station} indicates engagement at the ischial spines).


Diagram of longitudinal vertex, longitudinal breech, and transverse shoulder presentations
  • Passage: The maternal pelvis.

    • Pelvic Types: Gynecoid (round inlet, ideal for vaginal birth), Android (heart-shaped, male-type, high rate of dystocia), Anthropoid (oval, favors occiput-posterior positions), Platypelloid (flat, wide transverse diameter).


Anatomical inlet shapes of the four pelvic classifications: gynecoid, platypelloid, android, and anthropoid
  • Stages and Phases of Labor:

    • First Stage: Cervical effacement and dilation to 10 cm10\,\text{cm}.

    • Latent Phase: Dilation 0−3 cm0-3\,\text{cm}; contractions mild to moderate every 3−30 minutes3-30\,\text{minutes}; maternal affect is talkative, excited, or mildly anxious.

    • Active Phase: Dilation 4−7 cm4-7\,\text{cm}; contractions every 2−5 minutes2-5\,\text{minutes}, lasting 40−60 seconds40-60\,\text{seconds}; woman becomes more focused, serious, and reliant on coaching.

    • Transition Phase: Dilation 8−10 cm8-10\,\text{cm}; contractions intense every 1.5−2 minutes1.5-2\,\text{minutes}, lasting 60−90 seconds60-90\,\text{seconds}; marked by rectal pressure, nausea, irritability, trembling thighs, and feelings of loss of control.

    • Second Stage: Full dilation (10 cm10\,\text{cm}) to delivery of the neonate; descent of the presenting part produces an involuntary urge to push.

    • Third Stage: Delivery of the placenta (5−30 minutes5-30\,\text{minutes} post-delivery); heralded by cord lengthening, a gush of blood, and uterine fundal rising.

    • Fourth Stage: Immediate postpartum physiological stabilization (1−4 hours1-4\,\text{hours} post-placenta); risk period for uterine atony and postpartum hemorrhage.

  • Intrapartum Nursing Support and Pushing Technique:

    • Fear-Tension-Pain Cycle: Severe anxiety elevates catecholamines, which reduces uterine blood flow and contraction coordination, increasing pain and labor duration.


Cycle diagram showing how fear, tension, and reduced uterine oxygenation escalate labor pain
  • Pushing Modalities: Sustained closed-glottis (Valsalva) pushing is discouraged because it impedes maternal venous return, lowers blood pressure, and reduces uteroplacental perfusion. Open-glottis, physiological pushing with exhalation optimizes oxygenation and shortens the second stage.

  • Nonpharmacological Comfort Interventions: Upright positioning (leverages gravity), walking, birth balls, hydrotherapy (tubs/showers), effleurage, sacral counterpressure, and controlled patterned breathing.